Alkaloid [EPC]

Alkaloid [EPC] was reported 26665 times

Drugs of the Alkaloid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 X-LINKED LYMPHOPROLIFERATIVE SYNDROME 24 0.7273
1 RED BLOOD CELL SEDIMENTATION RATE 128 0.4588
2 FAMILIAL MEDITERRANEAN FEVER 65 0.3316
3 SERUM AMYLOID A PROTEIN INCREASED 47 0.3032
4 HEART FAILURE WITH PRESERVED EJECTION FRACTION 87 0.2959
5 CENTRAL NERVOUS SYSTEM LUPUS 47 0.2108
6 BODY MASS INDEX ABNORMAL 46 0.1885
7 GOUTY TOPHUS 39 0.1757
8 GRANULOMA SKIN 139 0.1693
9 BEHCET'S SYNDROME 23 0.1620
10 ENTHESOPATHY 245 0.1565
11 AUTOINFLAMMATORY DISEASE 25 0.1179
12 TYPE 2 LEPRA REACTION 22 0.1176
13 BLOOD PARATHYROID HORMONE DECREASED 157 0.1059
14 SEROSITIS 57 0.1031
15 TENOSYNOVITIS 254 0.0920
16 MYOPATHY TOXIC 54 0.0874
17 NEUROMYOPATHY 88 0.0826
18 PANNICULITIS 188 0.0776
19 GOUTY ARTHRITIS 55 0.0689
20 ALANINE AMINOTRANSFERASE ABNORMAL 140 0.0663
21 GOUT 1108 0.0617
22 RHEUMATOID NODULE 163 0.0591
23 PLEUROPERICARDITIS 23 0.0558
24 URTICARIAL VASCULITIS 28 0.0530
25 MYOPERICARDITIS 40 0.0513
26 EPISCLERITIS 35 0.0507
27 PERICARDITIS CONSTRICTIVE 21 0.0498
28 RHEUMATOID LUNG 46 0.0482
29 CHONDROCALCINOSIS 31 0.0475
30 MUSCLE ABSCESS 27 0.0433
31 C-REACTIVE PROTEIN ABNORMAL 262 0.0408
32 DEFAECATION DISORDER 27 0.0403
33 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 41 0.0386
34 HYPERPARATHYROIDISM SECONDARY 86 0.0343
35 LUPUS NEPHRITIS 63 0.0337
36 DRUG TOLERANCE DECREASED 94 0.0334
37 CHONDROCALCINOSIS PYROPHOSPHATE 25 0.0323
38 HYPERSENSITIVITY VASCULITIS 84 0.0320
39 TONGUE DISORDER 229 0.0316
40 SKIN NECROSIS 164 0.0316
41 NEPHROGENIC ANAEMIA 137 0.0295
42 ENTEROCOCCAL SEPSIS 23 0.0284
43 LOSS OF EMPLOYMENT 85 0.0281
44 MYOPATHY 231 0.0267
45 PERICARDITIS 443 0.0263
46 PNEUMONIA STREPTOCOCCAL 26 0.0237
47 ECHOCARDIOGRAM ABNORMAL 33 0.0236
48 PERICARDIAL HAEMORRHAGE 50 0.0228
49 VASCULAR PURPURA 27 0.0193
50 GRANULOMA 66 0.0190
51 CARDIAC TAMPONADE 87 0.0183
52 SECONDARY ADRENOCORTICAL INSUFFICIENCY 27 0.0179
53 MYOCARDIAL INJURY 20 0.0178
54 BLOOD URIC ACID INCREASED 101 0.0175
55 HYPERPHOSPHATAEMIA 35 0.0163
56 CUTANEOUS VASCULITIS 59 0.0161
57 WHITE BLOOD CELLS URINE POSITIVE 30 0.0159
58 ESSENTIAL HYPERTENSION 29 0.0158
59 TENDONITIS 245 0.0158
60 BLOOD PRESSURE DIASTOLIC ABNORMAL 40 0.0157
61 HYPERCALCAEMIA 194 0.0157
62 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 36 0.0155
63 RED BLOOD CELL SEDIMENTATION RATE INCREASED 167 0.0151
64 MULTIPLE ORGAN DYSFUNCTION SYNDROME 426 0.0150
65 ULCER 237 0.0149
66 SYNOVITIS 268 0.0148
67 PERICARDIAL EFFUSION 324 0.0140
68 CARDIOGENIC SHOCK 201 0.0140
69 LABELLED DRUG-DRUG INTERACTION ISSUE 20 0.0138
70 REBOUND ACID HYPERSECRETION 41 0.0135
71 END STAGE RENAL DISEASE 241 0.0132
72 BASAL CELL CARCINOMA 206 0.0132
73 ORTHOPNOEA 42 0.0132
74 RHABDOMYOLYSIS 531 0.0127
75 RESPIRATORY ACIDOSIS 50 0.0127
76 MIXED LIVER INJURY 38 0.0126
77 TROPONIN I INCREASED 21 0.0126
78 BICYTOPENIA 24 0.0122
79 VASOPLEGIA SYNDROME 20 0.0122
80 FEAR OF INJECTION 86 0.0120
81 LEUKOCYTOSIS 218 0.0120
82 GROWTH RETARDATION 34 0.0115
83 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 291 0.0113
84 DRUG TOLERANCE 57 0.0113
85 NEPHROGENIC SYSTEMIC FIBROSIS 34 0.0112
86 CONTRAINDICATED PRODUCT ADMINISTERED 339 0.0112
87 HEPATOSPLENOMEGALY 28 0.0109
88 MYOCARDITIS 124 0.0108
89 SKIN INDURATION 22 0.0106
90 DRUG ERUPTION 188 0.0106
91 ARTHRITIS INFECTIVE 49 0.0106
92 HYPERURICAEMIA 42 0.0102
93 JOINT NOISE 20 0.0102
94 THROMBOCYTOSIS 37 0.0101
95 BLOOD PRESSURE SYSTOLIC DECREASED 45 0.0099
96 HAEMORRHAGIC DIATHESIS 35 0.0098
97 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 26 0.0098
98 BLOOD PRESSURE SYSTOLIC ABNORMAL 24 0.0097
99 METABOLIC ACIDOSIS 310 0.0097
100 CYTOLYTIC HEPATITIS 32 0.0096
101 RENAL FAILURE CHRONIC 74 0.0096
102 PYODERMA GANGRENOSUM 34 0.0094
103 CORONARY ARTERY THROMBOSIS 19 0.0094
104 JAUNDICE CHOLESTATIC 33 0.0093
105 SKIN ULCER 239 0.0092
106 BLOOD PRESSURE SYSTOLIC INCREASED 180 0.0092
107 CARDIAC DYSFUNCTION 34 0.0091
108 C-REACTIVE PROTEIN INCREASED 328 0.0090
109 APPETITE DISORDER 59 0.0089
110 DISTRIBUTIVE SHOCK 20 0.0088
111 ISCHAEMIC CARDIOMYOPATHY 27 0.0088
112 MYOSITIS 78 0.0087
113 ACUTE KIDNEY INJURY 1325 0.0086
114 CHRONIC KIDNEY DISEASE 654 0.0086
115 DISSEMINATED INTRAVASCULAR COAGULATION 121 0.0086
116 TYPE IV HYPERSENSITIVITY REACTION 23 0.0084
117 ASPARTATE AMINOTRANSFERASE INCREASED 445 0.0084
118 HEPATIC CYTOLYSIS 104 0.0081
119 TROPONIN INCREASED 62 0.0081
120 BLOOD CHLORIDE DECREASED 21 0.0081
121 CUSHINGOID 26 0.0081
122 HEPATIC STEATOSIS 149 0.0080
123 ERYTHEMA NODOSUM 28 0.0080
124 RENAL FAILURE ACUTE 336 0.0079
125 HYPOVOLAEMIA 46 0.0079
126 BRAIN NATRIURETIC PEPTIDE INCREASED 24 0.0078
127 DERMATITIS EXFOLIATIVE GENERALISED 27 0.0078
128 ATELECTASIS 75 0.0078
129 HYPOVOLAEMIC SHOCK 37 0.0077
130 BLOOD PRESSURE DIASTOLIC DECREASED 57 0.0077
131 HYPERVOLAEMIA 38 0.0077
132 PULSELESS ELECTRICAL ACTIVITY 32 0.0077
133 ABDOMINAL TENDERNESS 38 0.0076
134 SHOCK 175 0.0076
135 PLEURITIC PAIN 21 0.0076
136 CONJUNCTIVAL HAEMORRHAGE 29 0.0076
137 PANCYTOPENIA 422 0.0075
138 DRUG INTOLERANCE 729 0.0075
139 JOINT EFFUSION 52 0.0075
140 TOXICITY TO VARIOUS AGENTS 1269 0.0075
141 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
142 COAGULOPATHY 125 0.0075
143 HYPERLACTACIDAEMIA 20 0.0075
144 PLEURISY 44 0.0074
145 OLIGURIA 45 0.0072
146 RENAL TUBULAR NECROSIS 71 0.0072
147 MULTI-ORGAN FAILURE 125 0.0072
148 LUNG OPACITY 19 0.0072
149 DRUG INTERACTION 1131 0.0071
150 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 63 0.0071
151 APHTHOUS ULCER 55 0.0071
152 ALANINE AMINOTRANSFERASE INCREASED 432 0.0070
153 INFUSION SITE HAEMORRHAGE 23 0.0070
154 RED CELL DISTRIBUTION WIDTH INCREASED 29 0.0070
155 INFUSION SITE PRURITUS 22 0.0070
156 BLOOD PHOSPHORUS INCREASED 19 0.0070
157 TENDERNESS 72 0.0069
158 CHOLESTASIS 132 0.0069
159 GENERALISED ERYTHEMA 39 0.0069
160 NEUTROPHILIA 39 0.0068
161 POTENTIATING DRUG INTERACTION 23 0.0068
162 POLYARTHRITIS 36 0.0068
163 INTERNATIONAL NORMALISED RATIO INCREASED 194 0.0068
164 PSORIATIC ARTHROPATHY 276 0.0068
165 ANTINUCLEAR ANTIBODY POSITIVE 22 0.0068
166 SKIN HYPERTROPHY 19 0.0068
167 DYSPHORIA 34 0.0067
168 BODY TEMPERATURE DECREASED 66 0.0067
169 HYPERKALAEMIA 235 0.0067
170 HYPERLIPIDAEMIA 80 0.0067
171 TRICUSPID VALVE INCOMPETENCE 53 0.0067
172 CONCOMITANT DISEASE AGGRAVATED 41 0.0066
173 URINE OUTPUT DECREASED 58 0.0066
174 RENAL FAILURE 880 0.0066
175 THERAPY NON-RESPONDER 296 0.0066
176 RIGHT VENTRICULAR FAILURE 46 0.0066
177 BONE MARROW FAILURE 133 0.0065
178 VASCULITIS 76 0.0065
179 ATRIAL FLUTTER 52 0.0065
180 DYSLIPIDAEMIA 33 0.0065
181 CARDIOMYOPATHY 96 0.0065
182 JOINT INJURY 138 0.0065
183 SERUM FERRITIN INCREASED 34 0.0064
184 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 50 0.0064
185 GLUCOSE TOLERANCE IMPAIRED 38 0.0064
186 ACUTE RESPIRATORY FAILURE 123 0.0064
187 BLOOD CREATINE PHOSPHOKINASE INCREASED 184 0.0064
188 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 348 0.0063
189 DIVERTICULUM 45 0.0063
190 BLOOD UREA INCREASED 106 0.0063
191 FAECES SOFT 46 0.0063
192 BUNDLE BRANCH BLOCK RIGHT 29 0.0063
193 HEPATITIS ACUTE 41 0.0063
194 HAEMODYNAMIC INSTABILITY 48 0.0063
195 CARDIOMEGALY 77 0.0063
196 HYPOMAGNESAEMIA 86 0.0062
197 INTERNATIONAL NORMALISED RATIO DECREASED 25 0.0062
198 INFUSION SITE ERYTHEMA 52 0.0062
199 PURPURA 54 0.0061
200 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 293 0.0061
201 ARTHRITIS BACTERIAL 25 0.0061
202 DIABETIC NEUROPATHY 30 0.0061
203 REBOUND EFFECT 68 0.0060
204 BENIGN PROSTATIC HYPERPLASIA 31 0.0060
205 DRUG RESISTANCE 154 0.0060
206 INFLAMMATION 309 0.0060
207 TOXIC EPIDERMAL NECROLYSIS 90 0.0059
208 ACIDOSIS 45 0.0059
209 FOOD ALLERGY 45 0.0058
210 AORTIC STENOSIS 20 0.0057
211 ACUTE HEPATIC FAILURE 78 0.0057
212 HAEMORRHAGIC ANAEMIA 25 0.0057
213 TUBULOINTERSTITIAL NEPHRITIS 106 0.0057
214 BLOOD CREATININE INCREASED 366 0.0056
215 MOUTH ULCERATION 118 0.0056
216 MATERNAL EXPOSURE TIMING UNSPECIFIED 21 0.0056
217 ABNORMAL LOSS OF WEIGHT 38 0.0056
218 HEART RATE ABNORMAL 31 0.0056
219 RALES 32 0.0055
220 MONOCYTE COUNT INCREASED 20 0.0055
221 HAEMOGLOBIN INCREASED 25 0.0055
222 BREATH SOUNDS ABNORMAL 27 0.0055
223 RASH MACULO-PAPULAR 121 0.0054
224 BUNDLE BRANCH BLOCK LEFT 23 0.0054
225 PROTHROMBIN TIME PROLONGED 32 0.0053
226 HYDRONEPHROSIS 40 0.0053
227 SKIN PLAQUE 45 0.0053
228 SKIN WARM 31 0.0053
229 BLOOD LACTIC ACID INCREASED 28 0.0053
230 UPPER GASTROINTESTINAL HAEMORRHAGE 89 0.0053
231 VITAMIN D DECREASED 45 0.0053
232 TONGUE OEDEMA 20 0.0052
233 HYPOCALCAEMIA 99 0.0052
234 TREATMENT FAILURE 433 0.0052
235 ENTEROCOLITIS 30 0.0052
236 EOSINOPHILIA 91 0.0052
237 RENAL INJURY 154 0.0052
238 THERAPEUTIC PRODUCT EFFECT DECREASED 232 0.0052
239 HEPATOCELLULAR INJURY 73 0.0051
240 SUSPECTED SUICIDE 24 0.0051
241 ASPIRATION 56 0.0051
242 CARDIAC FAILURE ACUTE 34 0.0051
243 CLOSTRIDIUM DIFFICILE COLITIS 54 0.0051
244 CARDIAC FAILURE CONGESTIVE 408 0.0051
245 ACCIDENTAL EXPOSURE 21 0.0050
246 RENAL IMPAIRMENT 421 0.0050
247 LEUKOPENIA 247 0.0049
248 MATERNAL EXPOSURE DURING BREAST FEEDING 20 0.0049
249 LEFT VENTRICULAR HYPERTROPHY 21 0.0049
250 INTENTIONAL OVERDOSE 314 0.0049
251 INFUSION SITE PAIN 63 0.0049
252 HYPERTRANSAMINASAEMIA 34 0.0049
253 THERAPY PARTIAL RESPONDER 76 0.0049
254 OSTEOMYELITIS 88 0.0049
255 MITRAL VALVE INCOMPETENCE 55 0.0049
256 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 33 0.0048
257 HEPATOTOXICITY 108 0.0048
258 VENTRICULAR TACHYCARDIA 80 0.0048
259 HEPATIC FAILURE 146 0.0048
260 ARTHRITIS 380 0.0048
261 ANGIOPATHY 27 0.0048
262 SHOCK HAEMORRHAGIC 39 0.0048
263 RASH PRURITIC 259 0.0048
264 INFUSION SITE SWELLING 30 0.0048
265 TOXIC SKIN ERUPTION 48 0.0048
266 ANURIA 41 0.0048
267 ACUTE RESPIRATORY DISTRESS SYNDROME 84 0.0047
268 MUSCLE ATROPHY 60 0.0047
269 UVEITIS 64 0.0047
270 HAEMATURIA 161 0.0047
271 ECONOMIC PROBLEM 70 0.0046
272 ANAPHYLACTOID REACTION 19 0.0046
273 SPLENOMEGALY 54 0.0046
274 THROMBOCYTOPENIA 513 0.0046
275 DRUG LEVEL ABOVE THERAPEUTIC 21 0.0046
276 CELLULITIS 230 0.0046
277 GLOMERULAR FILTRATION RATE DECREASED 56 0.0046
278 CARDIAC VALVE DISEASE 26 0.0045
279 PANCREATITIS ACUTE 102 0.0045
280 RENAL CYST 36 0.0045
281 GENERALISED OEDEMA 56 0.0045
282 CORONARY ARTERY DISEASE 136 0.0045
283 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
284 LIVER FUNCTION TEST INCREASED 96 0.0045
285 IRON DEFICIENCY 20 0.0044
286 HYPERTRIGLYCERIDAEMIA 26 0.0044
287 SINUS CONGESTION 60 0.0044
288 INFLAMMATORY MARKER INCREASED 22 0.0044
289 PULMONARY HYPERTENSION 92 0.0044
290 AGRANULOCYTOSIS 82 0.0044
291 VASCULAR DEVICE INFECTION 20 0.0044
292 NEPHROPATHY 41 0.0044
293 ARTERIOSCLEROSIS CORONARY ARTERY 29 0.0044
294 LACTIC ACIDOSIS 141 0.0043
295 INFUSION RELATED REACTION 288 0.0043
296 GUILLAIN-BARRE SYNDROME 21 0.0043
297 CARDIAC FAILURE 348 0.0043
298 BLOOD PRESSURE FLUCTUATION 104 0.0043
299 VENTRICULAR FIBRILLATION 48 0.0043
300 GASTROINTESTINAL MOTILITY DISORDER 23 0.0043
301 PULMONARY MASS 64 0.0043
302 WRONG PRODUCT ADMINISTERED 29 0.0043
303 MULTIPLE INJURIES 27 0.0043
304 PERIPHERAL VASCULAR DISORDER 22 0.0043
305 HYPERAESTHESIA 35 0.0043
306 JOINT RANGE OF MOTION DECREASED 57 0.0042
307 COMPLETED SUICIDE 354 0.0042
308 COLITIS MICROSCOPIC 20 0.0042
309 PETECHIAE 44 0.0042
310 MUSCULOSKELETAL DISORDER 80 0.0042
311 ATRIAL FIBRILLATION 409 0.0042
312 SKIN HYPERPIGMENTATION 36 0.0042
313 LIVER INJURY 102 0.0042
314 KLEBSIELLA INFECTION 21 0.0041
315 PULMONARY FIBROSIS 79 0.0041
316 BLOOD PRESSURE DIASTOLIC INCREASED 19 0.0041
317 PLEURAL EFFUSION 250 0.0041
318 HEART RATE IRREGULAR 92 0.0041
319 LYMPHADENOPATHY 144 0.0041
320 FLANK PAIN 38 0.0040
321 STAPHYLOCOCCAL SEPSIS 20 0.0040
322 STEVENS-JOHNSON SYNDROME 90 0.0040
323 FAILURE TO THRIVE 21 0.0040
324 SKIN TIGHTNESS 19 0.0040
325 OSTEOARTHRITIS 171 0.0040
326 IRON DEFICIENCY ANAEMIA 37 0.0040
327 MELAENA 88 0.0040
328 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 30 0.0040
329 HAEMATOCRIT DECREASED 79 0.0040
330 BLOOD LACTATE DEHYDROGENASE INCREASED 63 0.0040
331 TENDON RUPTURE 49 0.0040
332 ACUTE MYOCARDIAL INFARCTION 117 0.0040
333 MUSCULOSKELETAL STIFFNESS 346 0.0039
334 HYPOXIA 139 0.0039
335 ILEUS 49 0.0039
336 RHEUMATOID ARTHRITIS 446 0.0039
337 TRANSAMINASES INCREASED 87 0.0039
338 ANGIOEDEMA 173 0.0039
339 ENTERITIS 25 0.0039
340 SEASONAL ALLERGY 55 0.0039
341 GRIP STRENGTH DECREASED 34 0.0039
342 SEPTIC SHOCK 168 0.0039
343 DIARRHOEA 2458 0.0038
344 PULMONARY ARTERIAL HYPERTENSION 55 0.0038
345 ECCHYMOSIS 26 0.0038
346 ATRIOVENTRICULAR BLOCK 29 0.0037
347 HYPOTENSION 752 0.0037
348 SINUS TACHYCARDIA 53 0.0037
349 RESPIRATORY RATE INCREASED 33 0.0037
350 OEDEMA PERIPHERAL 453 0.0037
351 GASTROINTESTINAL DISORDER 332 0.0037
352 OBESITY 59 0.0037
353 PHARYNGITIS STREPTOCOCCAL 40 0.0037
354 RESPIRATORY DISTRESS 102 0.0037
355 RESPIRATORY TRACT INFECTION 96 0.0037
356 TACHYPNOEA 50 0.0037
357 OEDEMA 199 0.0037
358 BLOOD ALBUMIN DECREASED 29 0.0037
359 HEPATITIS CHOLESTATIC 22 0.0036
360 SQUAMOUS CELL CARCINOMA OF SKIN 22 0.0036
361 NEUTROPENIC SEPSIS 26 0.0036
362 PULMONARY OEDEMA 163 0.0036
363 WEIGHT FLUCTUATION 38 0.0036
364 ADRENAL INSUFFICIENCY 44 0.0036
365 DISEASE RECURRENCE 172 0.0036
366 ELECTROLYTE IMBALANCE 42 0.0036
367 ATRIOVENTRICULAR BLOCK COMPLETE 24 0.0036
368 CARDIAC MURMUR 31 0.0036
369 GASTROINTESTINAL HAEMORRHAGE 299 0.0036
370 PERIPHERAL SWELLING 550 0.0036
371 ACUTE PULMONARY OEDEMA 20 0.0036
372 SLEEP APNOEA SYNDROME 68 0.0036
373 BLOOD CALCIUM DECREASED 40 0.0036
374 HEPATITIS 91 0.0036
375 HEPATIC ENZYME INCREASED 242 0.0035
376 EJECTION FRACTION DECREASED 55 0.0035
377 HERPES SIMPLEX 23 0.0035
378 JOINT SWELLING 427 0.0035
379 THERAPEUTIC RESPONSE DECREASED 214 0.0035
380 SPINAL OSTEOARTHRITIS 31 0.0035
381 HYPOPHOSPHATAEMIA 26 0.0035
382 SQUAMOUS CELL CARCINOMA 33 0.0035
383 ABDOMINAL PAIN 808 0.0035
384 LIVER FUNCTION TEST ABNORMAL 101 0.0035
385 SKIN DISORDER 115 0.0034
386 POST PROCEDURAL INFECTION 28 0.0034
387 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
388 WOUND 96 0.0034
389 CARDIAC ARREST 283 0.0034
390 DYSPNOEA EXERTIONAL 129 0.0034
391 CHEST PAIN 634 0.0034
392 NEUTROPHIL COUNT INCREASED 35 0.0034
393 BRONCHIECTASIS 23 0.0034
394 MOUTH HAEMORRHAGE 25 0.0034
395 MALNUTRITION 38 0.0034
396 CLOSTRIDIUM DIFFICILE INFECTION 74 0.0034
397 LIVER DISORDER 150 0.0034
398 VENTRICULAR EXTRASYSTOLES 35 0.0034
399 FLUID OVERLOAD 49 0.0034
400 HAEMOLYSIS 26 0.0034
401 GASTRIC DISORDER 115 0.0033
402 SYMPTOM RECURRENCE 20 0.0033
403 HAEMOPTYSIS 93 0.0033
404 OSTEOPOROSIS 136 0.0033
405 PHARYNGITIS 41 0.0033
406 RESPIRATORY FAILURE 241 0.0033
407 DIZZINESS POSTURAL 32 0.0033
408 HYPOKALAEMIA 152 0.0033
409 ARTHRALGIA 1356 0.0033
410 GENERAL PHYSICAL HEALTH DETERIORATION 376 0.0032
411 HEPATIC FUNCTION ABNORMAL 121 0.0032
412 JOINT STIFFNESS 85 0.0032
413 ARTHROPATHY 180 0.0032
414 SEPSIS 361 0.0032
415 PLATELET COUNT INCREASED 42 0.0032
416 DRUG-INDUCED LIVER INJURY 101 0.0032
417 BURSITIS 39 0.0032
418 PREMATURE DELIVERY 51 0.0032
419 BLOOD POTASSIUM INCREASED 52 0.0032
420 HAEMATEMESIS 81 0.0032
421 ARTERIOSCLEROSIS 30 0.0032
422 CARDIAC PACEMAKER INSERTION 19 0.0032
423 ASCITES 93 0.0032
424 SYSTEMIC LUPUS ERYTHEMATOSUS 112 0.0032
425 GANGRENE 19 0.0031
426 CARPAL TUNNEL SYNDROME 44 0.0031
427 DEFAECATION URGENCY 22 0.0031
428 PRODUCTIVE COUGH 149 0.0031
429 LYMPHOPENIA 44 0.0031
430 HYPERCHOLESTEROLAEMIA 30 0.0031
431 BLOOD ALKALINE PHOSPHATASE INCREASED 77 0.0031
432 DEHYDRATION 413 0.0031
433 HAEMODIALYSIS 26 0.0031
434 ABDOMINAL DISCOMFORT 519 0.0031
435 MYOCARDIAL ISCHAEMIA 35 0.0031
436 MYALGIA 522 0.0031
437 GLAUCOMA 59 0.0031
438 HAEMOGLOBIN DECREASED 314 0.0031
439 GASTRIC ULCER 58 0.0030
440 ANHEDONIA 80 0.0030
441 EAR PAIN 59 0.0030
442 LIMB INJURY 82 0.0030
443 DRUG TOXICITY 41 0.0030
444 IMPAIRED GASTRIC EMPTYING 41 0.0030
445 LIPASE INCREASED 23 0.0030
446 ORAL PAIN 67 0.0030
447 SUICIDE ATTEMPT 180 0.0030
448 RENAL DISORDER 138 0.0030
449 DRUG LEVEL INCREASED 49 0.0030
450 ANAEMIA 564 0.0030
451 MENTAL STATUS CHANGES 82 0.0029
452 LUNG INFILTRATION 26 0.0029
453 CONDITION AGGRAVATED 891 0.0029
454 HAEMORRHOIDS 57 0.0029
455 MUSCULOSKELETAL CHEST PAIN 45 0.0029
456 ACUTE CORONARY SYNDROME 24 0.0029
457 BLOOD MAGNESIUM DECREASED 25 0.0029
458 HYPERTENSION 611 0.0029
459 STAPHYLOCOCCAL INFECTION 95 0.0029
460 GASTROENTERITIS 42 0.0029
461 VITAMIN D DEFICIENCY 28 0.0029
462 FLUID RETENTION 146 0.0029
463 LUPUS-LIKE SYNDROME 26 0.0029
464 ORAL DISORDER 21 0.0029
465 CHOLECYSTITIS 34 0.0029
466 GAMMA-GLUTAMYLTRANSFERASE INCREASED 63 0.0028
467 HYPONATRAEMIA 160 0.0028
468 QUALITY OF LIFE DECREASED 38 0.0028
469 HYPOKINESIA 41 0.0028
470 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
471 DYSSTASIA 82 0.0028
472 SINUS BRADYCARDIA 27 0.0028
473 MUSCLE STRAIN 24 0.0028
474 NECK PAIN 155 0.0028
475 MYOCLONUS 33 0.0028
476 WHITE BLOOD CELL COUNT INCREASED 106 0.0028
477 EPISTAXIS 206 0.0028
478 PAIN IN JAW 78 0.0028
479 HEPATOMEGALY 27 0.0027
480 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 195 0.0027
481 MIOSIS 22 0.0027
482 SKIN LESION 75 0.0027
483 LETHARGY 157 0.0027
484 PNEUMONIA BACTERIAL 25 0.0027
485 MOBILITY DECREASED 195 0.0027
486 PHOTOPHOBIA 51 0.0027
487 HIATUS HERNIA 35 0.0027
488 MUSCULAR WEAKNESS 307 0.0027
489 CORONARY ARTERY OCCLUSION 37 0.0027
490 POLYURIA 22 0.0027
491 MULTIPLE ALLERGIES 21 0.0027
492 HEART RATE DECREASED 94 0.0027
493 APPENDICITIS 25 0.0027
494 MUSCULOSKELETAL DISCOMFORT 46 0.0027
495 VOMITING 1253 0.0027
496 CANDIDA INFECTION 45 0.0027
497 BLOOD POTASSIUM DECREASED 80 0.0027
498 NEPHROLITHIASIS 122 0.0027
499 RECTAL HAEMORRHAGE 114 0.0027
500 LOCALISED INFECTION 64 0.0026
501 PALLOR 72 0.0026
502 FOOT FRACTURE 50 0.0026
503 OSTEOPENIA 40 0.0026
504 PYREXIA 909 0.0026
505 ERYTHEMA 540 0.0026
506 PRODUCT ADMINISTRATION ERROR 53 0.0026
507 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
508 TUMOUR LYSIS SYNDROME 23 0.0026
509 HEREDITARY ANGIOEDEMA 28 0.0026
510 RHINITIS 21 0.0026
511 PNEUMONIA ASPIRATION 65 0.0026
512 ACCIDENTAL OVERDOSE 95 0.0026
513 BLISTER 145 0.0026
514 OFF LABEL USE 2256 0.0026
515 HAEMOLYTIC ANAEMIA 23 0.0026
516 MYELODYSPLASTIC SYNDROME 37 0.0026
517 IMMUNODEFICIENCY 38 0.0025
518 RENAL PAIN 27 0.0025
519 LYMPHOCYTE COUNT DECREASED 45 0.0025
520 INTERSTITIAL LUNG DISEASE 123 0.0025
521 FAECES DISCOLOURED 55 0.0025
522 CATARACT 151 0.0025
523 COUGH 709 0.0025
524 ORTHOSTATIC HYPOTENSION 44 0.0025
525 PROTEINURIA 48 0.0025
526 HYPOPHAGIA 64 0.0025
527 PULMONARY CONGESTION 33 0.0025
528 NEUTROPENIA 340 0.0025
529 INCREASED TENDENCY TO BRUISE 23 0.0025
530 RED BLOOD CELL COUNT DECREASED 71 0.0025
531 EMPHYSEMA 25 0.0025
532 BLOOD PRESSURE DECREASED 164 0.0025
533 OVERDOSE 530 0.0025
534 CONTUSION 236 0.0024
535 CYTOPENIA 30 0.0024
536 HYPOALBUMINAEMIA 19 0.0024
537 MYELOSUPPRESSION 88 0.0024
538 OROPHARYNGEAL DISCOMFORT 22 0.0024
539 HAEMATOMA 63 0.0024
540 RIB FRACTURE 50 0.0024
541 TOOTH DISORDER 54 0.0024
542 ANKYLOSING SPONDYLITIS 32 0.0024
543 DYSPNOEA 1373 0.0024
544 ANAPHYLACTIC REACTION 134 0.0024
545 METASTASES TO LUNG 28 0.0024
546 ARTERIAL OCCLUSIVE DISEASE 19 0.0024
547 SNEEZING 54 0.0024
548 NEPHROPATHY TOXIC 27 0.0024
549 EYE HAEMORRHAGE 32 0.0024
550 DIALYSIS 34 0.0024
551 GAIT INABILITY 80 0.0024
552 GROIN PAIN 21 0.0024
553 UROSEPSIS 22 0.0024
554 ABSCESS 38 0.0024
555 OESOPHAGITIS 26 0.0024
556 BRADYCARDIA 126 0.0024
557 DRUG LEVEL DECREASED 24 0.0024
558 DIARRHOEA HAEMORRHAGIC 22 0.0024
559 BACK PAIN 546 0.0023
560 DYSPHONIA 137 0.0023
561 ANGINA PECTORIS 67 0.0023
562 UPPER RESPIRATORY TRACT INFECTION 108 0.0023
563 BLOOD PRESSURE INCREASED 357 0.0023
564 PSEUDOMONAS INFECTION 20 0.0023
565 PNEUMONIA 755 0.0023
566 OXYGEN SATURATION DECREASED 131 0.0023
567 INFECTION 337 0.0023
568 POOR VENOUS ACCESS 24 0.0023
569 BLOOD URINE PRESENT 44 0.0023
570 TASTE DISORDER 47 0.0023
571 DECREASED APPETITE 538 0.0023
572 OCULAR DISCOMFORT 26 0.0023
573 RESTLESS LEGS SYNDROME 42 0.0023
574 PYELONEPHRITIS 20 0.0023
575 ASTHENIA 867 0.0023
576 ORAL HERPES 45 0.0023
577 HIDRADENITIS 21 0.0023
578 SKIN LACERATION 25 0.0023
579 GASTROOESOPHAGEAL REFLUX DISEASE 185 0.0023
580 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
581 NAUSEA 1818 0.0023
582 WEIGHT DECREASED 641 0.0023
583 TRANSFUSION 24 0.0023
584 HYPOGLYCAEMIA 111 0.0023
585 INTENTIONAL PRODUCT USE ISSUE 200 0.0023
586 BLOOD SODIUM DECREASED 43 0.0023
587 PAIN IN EXTREMITY 672 0.0023
588 RASH 994 0.0023
589 GASTRITIS 60 0.0023
590 EOSINOPHIL COUNT INCREASED 19 0.0023
591 INTERNAL HAEMORRHAGE 26 0.0023
592 SWELLING 212 0.0023
593 CONJUNCTIVITIS 42 0.0023
594 TOOTH ABSCESS 23 0.0023
595 SCIATICA 36 0.0023
596 DELIRIUM 78 0.0022
597 HAEMATOCHEZIA 124 0.0022
598 ARRHYTHMIA 106 0.0022
599 PARALYSIS 32 0.0022
600 CIRCULATORY COLLAPSE 38 0.0022
601 TEMPERATURE INTOLERANCE 23 0.0022
602 INTESTINAL OBSTRUCTION 84 0.0022
603 HOSPICE CARE 22 0.0022
604 INTESTINAL PERFORATION 25 0.0022
605 PREMATURE BABY 67 0.0022
606 LIP SWELLING 74 0.0022
607 MASS 31 0.0022
608 CHILLS 260 0.0022
609 NASAL CONGESTION 130 0.0022
610 BLOOD TRIGLYCERIDES INCREASED 39 0.0022
611 BODY TEMPERATURE INCREASED 45 0.0022
612 HYPERSENSITIVITY 409 0.0022
613 HYPERGLYCAEMIA 80 0.0022
614 DERMATITIS CONTACT 25 0.0022
615 HEPATIC CIRRHOSIS 41 0.0022
616 PRODUCT USE ISSUE 410 0.0022
617 ROTATOR CUFF SYNDROME 28 0.0022
618 MUCOSAL INFLAMMATION 57 0.0022
619 CYST 27 0.0022
620 PNEUMONITIS 59 0.0022
621 BLOOD CALCIUM INCREASED 19 0.0022
622 CYTOMEGALOVIRUS INFECTION 36 0.0022
623 FOOT DEFORMITY 24 0.0022
624 LIMB DISCOMFORT 67 0.0022
625 BLOOD PRESSURE ABNORMAL 43 0.0022
626 PRODUCT PRESCRIBING ISSUE 47 0.0022
627 DRY MOUTH 175 0.0022
628 TOOTHACHE 39 0.0022
629 ABDOMINAL PAIN UPPER 443 0.0021
630 POISONING 27 0.0021
631 PHARYNGEAL SWELLING 21 0.0021
632 BACTERIAL INFECTION 40 0.0021
633 NOCTURIA 26 0.0021
634 HYPERTHYROIDISM 31 0.0021
635 URTICARIA 354 0.0021
636 FATIGUE 1644 0.0021
637 URINARY TRACT INFECTION 360 0.0021
638 ABDOMINAL DISTENSION 220 0.0021
639 OROPHARYNGEAL PAIN 195 0.0021
640 BRAIN FOG 33 0.0021
641 CARDIO-RESPIRATORY ARREST 88 0.0021
642 SCAB 24 0.0021
643 RHINORRHOEA 136 0.0021
644 SCAR 36 0.0021
645 WOUND INFECTION 23 0.0021
646 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
647 HEART RATE INCREASED 207 0.0021
648 TACHYCARDIA 185 0.0021
649 NIGHT SWEATS 67 0.0021
650 FACE OEDEMA 35 0.0021
651 PHOTOSENSITIVITY REACTION 34 0.0021
652 DIVERTICULITIS 57 0.0021
653 AUTOIMMUNE DISORDER 20 0.0020
654 GINGIVAL BLEEDING 28 0.0020
655 SPINAL PAIN 24 0.0020
656 CHOLELITHIASIS 67 0.0020
657 HEADACHE 1280 0.0020
658 NEUROPATHY PERIPHERAL 194 0.0020
659 CYANOSIS 32 0.0020
660 BACTERAEMIA 24 0.0020
661 SINUS DISORDER 40 0.0020
662 COVID-19 354 0.0020
663 PRESYNCOPE 49 0.0020
664 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 105 0.0020
665 MUSCULOSKELETAL PAIN 105 0.0020
666 LOSS OF CONSCIOUSNESS 256 0.0020
667 NODULE 26 0.0020
668 KIDNEY INFECTION 39 0.0020
669 TRANSIENT ISCHAEMIC ATTACK 67 0.0020
670 TREATMENT NONCOMPLIANCE 108 0.0020
671 WHEEZING 117 0.0020
672 PERIPHERAL COLDNESS 27 0.0020
673 HALLUCINATION 148 0.0020
674 EXPOSURE DURING PREGNANCY 122 0.0020
675 ISCHAEMIC STROKE 35 0.0020
676 BRONCHITIS 145 0.0020
677 DIABETES MELLITUS 149 0.0020
678 COLITIS 74 0.0020
679 LYMPHOMA 30 0.0019
680 DYSPHAGIA 184 0.0019
681 THINKING ABNORMAL 36 0.0019
682 HYPERBILIRUBINAEMIA 20 0.0019
683 HEAD INJURY 61 0.0019
684 MEDICATION ERROR 107 0.0019
685 POLYNEUROPATHY 23 0.0019
686 PRODUCT USE IN UNAPPROVED INDICATION 475 0.0019
687 HYPOTHYROIDISM 61 0.0019
688 GASTROINTESTINAL PAIN 21 0.0019
689 DERMATITIS ALLERGIC 24 0.0019
690 FLATULENCE 108 0.0019
691 SYNCOPE 190 0.0019
692 MALAISE 832 0.0019
693 TOOTH INFECTION 25 0.0019
694 NEURALGIA 46 0.0019
695 CARDIOVASCULAR DISORDER 48 0.0019
696 WEIGHT INCREASED 421 0.0019
697 INTERVERTEBRAL DISC PROTRUSION 41 0.0019
698 FEBRILE NEUTROPENIA 124 0.0019
699 DERMATITIS 39 0.0019
700 PANCREATITIS 98 0.0019
701 BLOOD IRON DECREASED 22 0.0019
702 FIBROMYALGIA 45 0.0018
703 PAIN 1136 0.0018
704 MACULAR DEGENERATION 22 0.0018
705 EAR INFECTION 49 0.0018
706 FULL BLOOD COUNT DECREASED 37 0.0018
707 SINUSITIS 188 0.0018
708 VIRAL INFECTION 61 0.0018
709 GASTROENTERITIS VIRAL 33 0.0018
710 FALL 608 0.0018
711 CONSTIPATION 398 0.0018
712 ORAL CANDIDIASIS 24 0.0018
713 JAUNDICE 49 0.0018
714 PALPITATIONS 213 0.0018
715 DISCOMFORT 110 0.0018
716 NERVE INJURY 20 0.0018
717 CHEST DISCOMFORT 183 0.0018
718 HYPOAESTHESIA 267 0.0018
719 SKIN INFECTION 20 0.0018
720 BLOOD COUNT ABNORMAL 27 0.0018
721 BLOOD TEST ABNORMAL 25 0.0018
722 BLOOD BILIRUBIN INCREASED 48 0.0018
723 GAIT DISTURBANCE 339 0.0018
724 SKIN DISCOLOURATION 81 0.0018
725 COLD SWEAT 31 0.0018
726 DYSPEPSIA 173 0.0018
727 DEVICE RELATED INFECTION 27 0.0018
728 SUBDURAL HAEMATOMA 25 0.0017
729 PULMONARY THROMBOSIS 19 0.0017
730 ABASIA 43 0.0017
731 LUNG DISORDER 85 0.0017
732 SWOLLEN TONGUE 54 0.0017
733 BONE PAIN 101 0.0017
734 TYPE 2 DIABETES MELLITUS 58 0.0017
735 IMPAIRED HEALING 56 0.0017
736 UNRESPONSIVE TO STIMULI 44 0.0017
737 RASH GENERALISED 44 0.0017
738 HYPERHIDROSIS 218 0.0017
739 FISTULA 19 0.0017
740 PLATELET COUNT DECREASED 180 0.0017
741 RETCHING 36 0.0017
742 GALLBLADDER DISORDER 30 0.0017
743 CARDIAC DISORDER 157 0.0017
744 HYPERSOMNIA 48 0.0017
745 BLOOD CHOLESTEROL INCREASED 78 0.0017
746 POOR QUALITY SLEEP 36 0.0017
747 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
748 EYE PAIN 94 0.0017
749 INJURY 117 0.0017
750 HALLUCINATION, VISUAL 35 0.0017
751 GASTRIC HAEMORRHAGE 19 0.0016
752 CONFUSIONAL STATE 266 0.0016
753 DEAFNESS 43 0.0016
754 ELECTROCARDIOGRAM QT PROLONGED 59 0.0016
755 BURNING SENSATION 115 0.0016
756 PNEUMOTHORAX 26 0.0016
757 RESPIRATORY DISORDER 49 0.0016
758 PARAESTHESIA 257 0.0016
759 NASOPHARYNGITIS 300 0.0016
760 ALOPECIA 319 0.0016
761 MYOCARDIAL INFARCTION 283 0.0016
762 ABDOMINAL PAIN LOWER 41 0.0016
763 INJECTION SITE EXTRAVASATION 20 0.0016
764 DRUG EFFECT LESS THAN EXPECTED 24 0.0016
765 URINARY RETENTION 54 0.0016
766 HIP FRACTURE 52 0.0016
767 COVID-19 PNEUMONIA 19 0.0016
768 LUNG INFECTION 25 0.0016
769 RASH PAPULAR 36 0.0016
770 RASH MACULAR 56 0.0016
771 IMPAIRED QUALITY OF LIFE 23 0.0016
772 DIZZINESS 797 0.0016
773 SWELLING FACE 104 0.0016
774 HOT FLUSH 120 0.0016
775 FRACTURE 30 0.0016
776 BLOOD GLUCOSE ABNORMAL 29 0.0016
777 RASH ERYTHEMATOUS 75 0.0016
778 THROAT IRRITATION 70 0.0016
779 DRUG INEFFECTIVE 2052 0.0016
780 DEEP VEIN THROMBOSIS 101 0.0016
781 PRODUCT PRESCRIBING ERROR 37 0.0016
782 INSOMNIA 413 0.0015
783 STOMATITIS 94 0.0015
784 DYSURIA 57 0.0015
785 CEREBRAL HAEMORRHAGE 55 0.0015
786 WHITE BLOOD CELL COUNT DECREASED 166 0.0015
787 MUSCLE SPASMS 281 0.0015
788 SLEEP DISORDER 108 0.0015
789 PRURITUS 583 0.0015
790 THROAT TIGHTNESS 41 0.0015
791 INFLUENZA 169 0.0015
792 HERPES ZOSTER 87 0.0015
793 ANAPHYLACTIC SHOCK 39 0.0015
794 INJECTION SITE WARMTH 31 0.0015
795 APHONIA 21 0.0015
796 HERNIA 29 0.0015
797 PRESCRIBED OVERDOSE 29 0.0015
798 SPINAL FRACTURE 30 0.0015
799 PERITONITIS 31 0.0015
800 LOWER RESPIRATORY TRACT INFECTION 68 0.0015
801 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
802 INTENTIONAL DOSE OMISSION 42 0.0015
803 DIABETIC KETOACIDOSIS 35 0.0015
804 UPPER LIMB FRACTURE 29 0.0015
805 HAEMORRHAGE 152 0.0015
806 FEELING HOT 89 0.0015
807 CYSTITIS 46 0.0014
808 AGEUSIA 36 0.0014
809 SKIN CANCER 31 0.0014
810 DISORIENTATION 57 0.0014
811 ILLNESS 148 0.0014
812 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 42 0.0014
813 MOVEMENT DISORDER 46 0.0014
814 THYROID DISORDER 22 0.0014
815 ENCEPHALOPATHY 35 0.0014
816 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 256 0.0014
817 POLLAKIURIA 59 0.0014
818 DYSARTHRIA 53 0.0014
819 INJECTION SITE URTICARIA 34 0.0014
820 PULMONARY EMBOLISM 131 0.0014
821 FLUSHING 140 0.0014
822 LOCAL SWELLING 24 0.0014
823 SOMNOLENCE 277 0.0014
824 INJECTION SITE RASH 42 0.0014
825 THROMBOSIS 110 0.0014
826 ERECTILE DYSFUNCTION 35 0.0014
827 DEMENTIA 38 0.0014
828 HEMIPARESIS 23 0.0014
829 ECZEMA 71 0.0014
830 INJECTION SITE REACTION 93 0.0014
831 SKIN REACTION 19 0.0013
832 DEPRESSED LEVEL OF CONSCIOUSNESS 53 0.0013
833 SPEECH DISORDER 70 0.0013
834 BRONCHOSPASM 19 0.0013
835 CHROMATURIA 30 0.0013
836 OCULAR HYPERAEMIA 63 0.0013
837 RESPIRATORY TRACT CONGESTION 21 0.0013
838 ASTHMA 149 0.0013
839 URINARY INCONTINENCE 39 0.0013
840 BLOOD GLUCOSE INCREASED 248 0.0013
841 ADVERSE EVENT 121 0.0013
842 UNEVALUABLE EVENT 99 0.0013
843 POST PROCEDURAL COMPLICATION 25 0.0013
844 MUSCLE TIGHTNESS 21 0.0013
845 ADVERSE DRUG REACTION 116 0.0013
846 DISEASE PROGRESSION 152 0.0013
847 FEEDING DISORDER 26 0.0013
848 CHOKING 25 0.0013
849 VISUAL IMPAIRMENT 158 0.0013
850 RESPIRATORY ARREST 35 0.0013
851 INTENTIONAL PRODUCT MISUSE 111 0.0013
852 DEPRESSION 288 0.0013
853 DISABILITY 25 0.0013
854 VERTIGO 77 0.0013
855 LACRIMATION INCREASED 38 0.0013
856 FEELING COLD 35 0.0013
857 HYPOACUSIS 54 0.0013
858 ANXIETY 356 0.0012
859 INSURANCE ISSUE 19 0.0012
860 DRY EYE 62 0.0012
861 BALANCE DISORDER 107 0.0012
862 BACK DISORDER 20 0.0012
863 ANKLE FRACTURE 19 0.0012
864 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
865 CEREBROVASCULAR ACCIDENT 207 0.0012
866 FREQUENT BOWEL MOVEMENTS 33 0.0012
867 LABORATORY TEST ABNORMAL 36 0.0012
868 EYE DISORDER 40 0.0012
869 TREMOR 201 0.0012
870 VISION BLURRED 166 0.0012
871 PRURITUS GENERALISED 26 0.0012
872 SURGERY 70 0.0012
873 KNEE ARTHROPLASTY 25 0.0012
874 THIRST 21 0.0012
875 MUSCLE TWITCHING 27 0.0012
876 PSORIASIS 151 0.0012
877 EYE SWELLING 43 0.0012
878 THERAPY INTERRUPTED 82 0.0011
879 COLITIS ULCERATIVE 51 0.0011
880 ILL-DEFINED DISORDER 69 0.0011
881 HOSPITALISATION 174 0.0011
882 MIGRAINE 108 0.0011
883 NERVOUS SYSTEM DISORDER 35 0.0011
884 IRRITABLE BOWEL SYNDROME 24 0.0011
885 SKIN EXFOLIATION 94 0.0011
886 FUNGAL INFECTION 37 0.0011
887 DYSGEUSIA 82 0.0011
888 DRY SKIN 146 0.0011
889 SEROTONIN SYNDROME 21 0.0011
890 LOWER LIMB FRACTURE 21 0.0011
891 BLINDNESS 44 0.0011
892 NEUTROPHIL COUNT DECREASED 44 0.0011
893 FEAR 29 0.0011
894 ROAD TRAFFIC ACCIDENT 45 0.0011
895 HEAD DISCOMFORT 19 0.0011
896 NERVOUSNESS 56 0.0011
897 COMA 51 0.0011
898 FEELING ABNORMAL 256 0.0011
899 PRODUCT DOSE OMISSION ISSUE 312 0.0011
900 PRODUCT AVAILABILITY ISSUE 24 0.0011
901 PSYCHOTIC DISORDER 31 0.0010
902 TINNITUS 48 0.0010
903 EMOTIONAL DISORDER 32 0.0010
904 AGITATION 76 0.0010
905 ERUCTATION 20 0.0010
906 EATING DISORDER 22 0.0010
907 MATERNAL EXPOSURE DURING PREGNANCY 92 0.0010
908 COGNITIVE DISORDER 48 0.0010
909 PRODUCT DOSE OMISSION 67 0.0010
910 OSTEONECROSIS 33 0.0010
911 CYTOKINE RELEASE SYNDROME 20 0.0010
912 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
913 INJECTION SITE BRUISING 79 0.0010
914 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
915 RESTLESSNESS 36 0.0010
916 AMNESIA 63 0.0010
917 CRYING 35 0.0010
918 APHASIA 29 0.0010
919 DYSKINESIA 39 0.0010
920 ABNORMAL BEHAVIOUR 38 0.0010
921 BLOOD GLUCOSE DECREASED 46 0.0010
922 PROCEDURAL PAIN 26 0.0009
923 INJECTION SITE ERYTHEMA 115 0.0009
924 EXTRAPYRAMIDAL DISORDER 23 0.0009
925 INJECTION SITE PRURITUS 62 0.0009
926 DIPLOPIA 24 0.0009
927 SKIN IRRITATION 42 0.0009
928 EPILEPSY 28 0.0009
929 THERAPY CESSATION 47 0.0009
930 PLASMA CELL MYELOMA 35 0.0009
931 EMOTIONAL DISTRESS 108 0.0009
932 MEMORY IMPAIRMENT 121 0.0009
933 DEATH 755 0.0009
934 THERAPEUTIC RESPONSE SHORTENED 29 0.0009
935 MENTAL DISORDER 38 0.0009
936 MENTAL IMPAIRMENT 21 0.0009
937 CEREBRAL INFARCTION 21 0.0009
938 OSTEONECROSIS OF JAW 21 0.0008
939 INFLUENZA LIKE ILLNESS 69 0.0008
940 VISUAL ACUITY REDUCED 27 0.0008
941 FOETAL EXPOSURE DURING PREGNANCY 65 0.0008
942 INJECTION SITE SWELLING 61 0.0008
943 MOOD ALTERED 21 0.0008
944 SUICIDAL IDEATION 70 0.0008
945 DEPRESSED MOOD 40 0.0008
946 NEEDLE ISSUE 22 0.0008
947 INCORRECT DOSE ADMINISTERED 168 0.0007
948 EYE IRRITATION 42 0.0007
949 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
950 INJECTION SITE MASS 26 0.0007
951 INJECTION SITE PAIN 214 0.0007
952 DRUG ADMINISTRATION ERROR 21 0.0007
953 CONVULSION 39 0.0007
954 DRUG EFFECT DECREASED 36 0.0007
955 PANIC ATTACK 24 0.0007
956 SEIZURE 75 0.0006
957 FEMUR FRACTURE 20 0.0006
958 DISTURBANCE IN ATTENTION 33 0.0006
959 EYE PRURITUS 19 0.0006
960 IRRITABILITY 34 0.0006
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
962 ANGER 19 0.0006
963 PRODUCT SUBSTITUTION ISSUE 32 0.0006
964 AGGRESSION 27 0.0005
965 DEVICE DISLOCATION 23 0.0005
966 INJECTION SITE HAEMORRHAGE 42 0.0005
967 NEOPLASM MALIGNANT 35 0.0005
968 DERMATITIS ATOPIC 27 0.0005
969 DRUG DOSE OMISSION 84 0.0005
970 EXTRA DOSE ADMINISTERED 20 0.0005
971 UNDERDOSE 35 0.0005
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 94 0.0005
973 LUNG NEOPLASM MALIGNANT 19 0.0005
974 VAGINAL HAEMORRHAGE 20 0.0005
975 MALIGNANT NEOPLASM PROGRESSION 47 0.0005
976 ACNE 34 0.0004
977 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
978 DEVICE ISSUE 40 0.0004
979 DEVICE LEAKAGE 19 0.0004
980 SKIN BURNING SENSATION 30 0.0004
981 NO ADVERSE EVENT 73 0.0004
982 DRUG ABUSE 32 0.0004
983 DEVICE MALFUNCTION 27 0.0004
984 PROSTATE CANCER 29 0.0004
985 DRUG WITHDRAWAL SYNDROME 29 0.0003
986 PRODUCT QUALITY ISSUE 44 0.0003
987 DRUG DEPENDENCE 51 0.0003
988 PRODUCT STORAGE ERROR 26 0.0003
989 BREAST CANCER 23 0.0002